Lardenoye JH - Search Results

1

Inhibition of accelerated atherosclerosis in vein grafts by placement of external stent in apoE*3-Leiden transgenic mice.

Lardenoye JH, De Vries MR, Grimbergen JM, Havekes LM, Knaapen MW, Kockx MM, van Hinsbergh VW, van Bockel JH, Quax PH. Lardenoye JH, et al. Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1433-8. doi: 10.1161/01.atv.0000030339.79524.6e. Arterioscler Thromb Vasc Biol. 2002. PMID: 12231562

2

Accelerated atherosclerosis and calcification in vein grafts: a study in APOE*3 Leiden transgenic mice.

Lardenoye JH, de Vries MR, Löwik CW, Xu Q, Dhore CR, Cleutjens JP, van Hinsbergh VW, van Bockel JH, Quax PH. Lardenoye JH, et al. Circ Res. 2002 Oct 4;91(7):577-84. doi: 10.1161/01.res.0000036901.58329.d7. Circ Res. 2002. PMID: 12364385

3

Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice.

Lardenoye JH, Delsing DJ, de Vries MR, Deckers MM, Princen HM, Havekes LM, van Hinsbergh VW, van Bockel JH, Quax PH. Lardenoye JH, et al. Circ Res. 2000 Aug 4;87(3):248-53. doi: 10.1161/01.res.87.3.248. Circ Res. 2000. PMID: 10926877

4

Survival of proximal third gastric carcinoma.

Lardenoye JW, Kappetein AP, Lagaay MB, Allema JH, Breslau PJ. Lardenoye JW, et al. J Surg Oncol. 1998 Jul;68(3):183-6. doi: 10.1002/(sici)1096-9098(199807)68:3<183::aid-jso10>3.0.co;2-2. J Surg Oncol. 1998. PMID: 9701212

5

Recording and classification of complications in a surgical practice.

Veen MR, Lardenoye JW, Kastelein GW, Breslau PJ. Veen MR, et al. Eur J Surg. 1999 May;165(5):421-4; discussion 425. doi: 10.1080/110241599750006622. Eur J Surg. 1999. PMID: 10391156

6

Inhibition of intimal hyperplasia by the tetracycline derived mmp inhibitor doxycycline in vein graft disease in vitro and in vivo.

Lardenoye JH, de Vries MR, Deckers M, van Lent N, Hanemaaijer R, van Bockel JH, Quax PH. Lardenoye JH, et al. EuroIntervention. 2005 Aug;1(2):236-43. EuroIntervention. 2005. PMID: 19758909

7

Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.

Quax PH, Lamfers ML, Lardenoye JH, Grimbergen JM, de Vries MR, Slomp J, de Ruiter MC, Kockx MM, Verheijen JH, van Hinsbergh VW. Quax PH, et al. Among authors: lardenoye jh. Circulation. 2001 Jan 30;103(4):562-9. doi: 10.1161/01.cir.103.4.562. Circulation. 2001. PMID: 11157723

8

In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.

Lamfers ML, Lardenoye JH, de Vries MR, Aalders MC, Engelse MA, Grimbergen JM, van Hinsbergh VW, Quax PH. Lamfers ML, et al. Among authors: lardenoye jh. Gene Ther. 2001 Apr;8(7):534-41. doi: 10.1038/sj.gt.3301437. Gene Ther. 2001. PMID: 11319620

9

Adenoviral activin a expression prevents intimal hyperplasia in human and murine blood vessels by maintaining the contractile smooth muscle cell phenotype.

Engelse MA, Lardenoye JH, Neele JM, Grimbergen JM, De Vries MR, Lamfers ML, Pannekoek H, Quax PH, De Vries CJ. Engelse MA, et al. Among authors: lardenoye jh. Circ Res. 2002 May 31;90(10):1128-34. doi: 10.1161/01.res.0000021044.53156.f5. Circ Res. 2002. PMID: 12039804

10

Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo.

van Weel V, Deckers MM, Grimbergen JM, van Leuven KJ, Lardenoye JH, Schlingemann RO, van Nieuw Amerongen GP, van Bockel JH, van Hinsbergh VW, Quax PH. van Weel V, et al. Among authors: lardenoye jh. Circ Res. 2004 Jul 9;95(1):58-66. doi: 10.1161/01.RES.0000133247.69803.c3. Epub 2004 May 20. Circ Res. 2004. PMID: 15155530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters